Skip to content
MarketScale
‹ Back to IndustriesBusiness Services

The Intake: How Atlas-SSI Helped Con Edison Find an Ideal 316(b) Solution

Passing a regulation is one thing. Complying with it is another. Con Edison had a big-time project on its hands when New York passed regulations that later were matched by the Aquatic Habitat Protection in Section 316(b) of the federal Clean Water Act. So, the company turned to Atlas-SSI for screens that would keep fish…

This story was produced through MarketScale. See how Business Services teams put it to work with Executive Thought Leadership.

Share
The Intake: How Atlas-SSI Helped Con Edison Find an Ideal 316(b) Solution

Get featured

Want MarketScale to feature Business Services?

Book a 15-minute demo and we'll map your Business Services expertise to the content buyers are searching for.

Book a demo

Passing a regulation is one thing. Complying with it is another.

Con Edison had a big-time project on its hands when New York passed regulations that later were matched by the Aquatic Habitat Protection in Section 316(b) of the federal Clean Water Act.

So, the company turned to Atlas-SSI for screens that would keep fish – and future fish – safer from harm while the plants continued operating.

There was just one problem. They’d have to pull it off with a facility located on the other side of the river from the intake system and do it across an enormous expanse.

“Because of 316b and having to flume the fish and larvae back out to the river safely, you needed a lot of additional spray wash water,” said Rodney Brown, Regional Sales Manager for Atlas-SSI. “So, there had to be bigger pumps, a new piping system and some new relief valves and, of course, a whole new set of controls was required to be able to operate it remotely out there.”

The new system required from 10-12 times as much water to pump everything effectively, said Gary Thorn, the Manager of Steam Plant Projects at Con Edison. He was confident Atlas-SSI could do the job after a site visit – one that went much better than another he experienced when he was putting together the bid list.

“They gave us a GPS coordinate of their facility and we ended up in a junkyard. I always tell people I would’ve been better off if I’d stayed in the junkyard than what I eventually saw when I got to their facility,” he said. “Those site visits to see the vendor and see their capabilities were really important for us to get that gut feel that we had somebody we could work with that had the capability to accomplish something we needed to accomplish.”

That’s exactly what Atlas-SSI’s screens did, even coping with some difficult scenarios during and immediately after Hurricane Sandy.

For the latest news, videos, and podcasts in the Building Management Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Business Services starts with a company putting its consultants, practice leads, and account teams on the record. Buyers are already reading this topic. The only question is whose experts they find.

Clients hire the firm whose thinking they have already read, which means fewer cold conversations for your partners.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Business Services Insights

Get new expert content in your inbox.

Business Services: are you visible to AI?

Before they reach out, Business Services buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Business Services expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your consultants, practice leads, and account teams into the articles, video, and social content Business Services buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Business Services Insights

The Early Scale: CNBC: IBM partners with OpenAI to boost enterprise AI

The Early Scale: CNBC: IBM partners with OpenAI to boost enterprise AI

IBM has partnered with OpenAI to enhance its enterprise AI solutions, aiming to improve B2B digital commerce and provide faster drug discovery. The partnership will allow IBM to leverage OpenAI’s technology, increasing its capability in AI-driven solutions for enterprises. The advancements in AI are anticipated to reduce drug discovery times significantly, impacting the pharmaceutical industry positively.

  • 01IBM is collaborating with OpenAI to enhance enterprise AI solutions.
  • 02AI is accelerating drug discovery processes, slashing development times to months.
  • 03B2B digital commerce is outpacing traditional market channels.

Aug 14, 2026

B2B digital commerce is outpacing broader e-commerce growth as distributor data confirm the shift

B2B digital commerce is outpacing broader e-commerce growth as distributor data confirm the shift

B2B digital commerce is growing more rapidly than the overall e-commerce market, as evidenced by significant digital sales growth reported by companies like Wesco, Watsco, and Fastenal in Q2 2026. This indicates a strong shift towards B2B e-commerce adoption. The trend suggests that digital transformation is significantly impacting the business services sector.

  • 01Wesco, Watsco, and Fastenal all reported double-digit digital sales growth in Q2 2026.
  • 02B2B e-commerce is growing faster than the overall e-commerce market.
  • 03The business services sector is experiencing a strong digital transformation shift.

Aug 13, 2026

The Early Scale: Forbes reports AI slashes drug discovery timelines to months

The Early Scale: Forbes reports AI slashes drug discovery timelines to months

Advancements in artificial intelligence are significantly reducing the timelines for drug discovery from years to just months. This shift is expected to have a profound impact on healthcare by accelerating the development of new treatments. The integration of AI is also posing challenges for other industries, particularly in manufacturing robotics and energy systems management.

  • 01AI reduces drug discovery timelines from years to months.
  • 02The healthcare industry will benefit from faster development of treatments.
  • 03Manufacturing robotics and energy systems face challenges with AI integration.

Aug 13, 2026

Explore More Business Services Insights

Read more expert perspectives from across Business Services.

Browse Business Services Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Business Services and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512